Is fosfomycin a potential treatment alternative for multidrug-resistant gram-negative prostatitis?

The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nat Rev Urol (2015) 1.25

Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches. Expert Opin Pharmacother (2014) 1.19

In vitro activity of fosfomycin alone and in combination with ceftriaxone or azithromycin against clinical Neisseria gonorrhoeae isolates. Antimicrob Agents Chemother (2014) 1.05

F33: A-: B-, IncHI2/ST3, and IncI1/ST71 plasmids drive the dissemination of fosA3 and bla CTX-M-55/-14/-65 in Escherichia coli from chickens in China. Front Microbiol (2014) 0.95

Fosfomycin. Clin Microbiol Rev (2016) 0.89

Long-Term Fosfomycin-Tromethamine Oral Therapy for Difficult-To-Treat Chronic Bacterial Prostatitis. Antimicrob Agents Chemother (2015) 0.87

Fosfomycin: Resurgence of an old companion. J Infect Chemother (2016) 0.86

Risk factors for infection following prostate biopsy - a case control study. BMC Infect Dis (2015) 0.80

Reducing Infectious Complications Following Transrectal Ultrasound-guided Prostate Biopsy: A Systematic Review. Rev Urol (2016) 0.77

The use of prophylactic single-dose fosfomycin in patients who undergo transrectal ultrasound-guided prostate biopsy: A prospective, randomized, and controlled clinical study. Can Urol Assoc J (2015) 0.77

Fosfomycin antimicrobial prophylaxis for transrectal ultrasound-guided biopsy of the prostate: A prospective randomised study. Arab J Urol (2016) 0.75

Re: Is Fosfomycin a Potential Treatment Alternative for Multidrug-Resistant Gram-Negative Prostatitis? J Urol (2015) 0.75

Differential characteristics of healthcare-associated compared to community-acquired febrile urinary tract infections in males. Eur J Clin Microbiol Infect Dis (2015) 0.75

Salvage radical prostatectomy following primary high intensity focused ultrasound for treatment of prostate cancer. J Urol (2011) 2.85

The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin Infect Dis (2008) 2.39

Extrathyroidal manifestations of Graves' disease: the thyrotropin receptor is expressed in extraocular, but not cardiac, muscle tissues. J Clin Endocrinol Metab (2001) 2.29

A protective role for protease-activated receptors in the airways. Nature (1999) 2.22

Prostate cancer in Victoria in 1993: patterns of reported management. Med J Aust (2000) 2.00

Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis. Clin Diagn Lab Immunol (1999) 1.97

Malaria acquired in Bali. Med J Aust (1995) 1.93

Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma. J Urol (2001) 1.92

Direct detection of vanB2 using the Roche LightCycler vanA/B detection assay to indicate vancomycin-resistant enterococcal carriage--sensitive but not specific. J Antimicrob Chemother (2007) 1.88

Comparison of three PCR primer sets for identification of vanB gene carriage in feces and correlation with carriage of vancomycin-resistant enterococci: interference by vanB-containing anaerobic bacilli. Antimicrob Agents Chemother (2005) 1.81

Enterococcal vanB resistance locus in anaerobic bacteria in human faeces. Lancet (2001) 1.60

Molecular characterization of vanB elements in naturally occurring gut anaerobes. Antimicrob Agents Chemother (2005) 1.58

Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA. Antimicrob Agents Chemother (2009) 1.50

A comparison of two dosing regimens of zidovudine in Thai adults with early symptomatic HIV infection. Conducting clinical HIV trials in South-East Asia. Aust N Z J Med (2000) 1.42

HIV in the suburbs. Med J Aust (1993) 1.38

A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. J Antimicrob Chemother (1996) 1.36

In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J Appl Bacteriol (1995) 1.34

Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiency. Clin Infect Dis (2010) 1.32

Laser ablation of the prostate in patients with benign prostatic hypertrophy. Br J Urol (1992) 1.32

High rates of fecal carriage of nonenterococcal vanB in both children and adults. Antimicrob Agents Chemother (2008) 1.29

Urologist directed percutaneous nephrostomy tube placement. J Urol (1994) 1.28

Angiotensin receptors: distribution, signalling and function. Clin Sci (Lond) (2001) 1.27

Impact of a toxicology service on a metropolitan teaching hospital. Emerg Med (Fremantle) (2001) 1.27

A quantitative assessment of the efficacy of surgical and N95 masks to filter influenza virus in patients with acute influenza infection. Clin Infect Dis (2009) 1.25

Random amplified polymorphic DNA and plasmid analyses used in investigation of an outbreak of multiresistant Klebsiella pneumoniae. J Clin Microbiol (1995) 1.25

Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PAR4 agonists. Circ Res (2001) 1.23

In vitro activity of sparfloxacin (AT-4140, CI-978, PD 131501), a new quinolone antimicrobial agent. Diagn Microbiol Infect Dis (1991) 1.19

Entrapped Malecot nephrostomy tube: etiology and management. J Urol (1995) 1.17

Psittacosis--a review of 135 cases. Med J Aust (1988) 1.17

Low-level vancomycin resistance in Staphylococcus aureus--an Australian perspective. Eur J Clin Microbiol Infect Dis (2005) 1.16

Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin. Med J Aust (2001) 1.15

Chlamydia pneumoniae as a new source of infectious outbreaks in nursing homes. JAMA (1997) 1.13

Optimum treatment of staphylococcal infections. Drugs (1993) 1.13

Comparison of the Xpert methicillin-resistant Staphylococcus aureus (MRSA) assay, BD GeneOhm MRSA assay, and culture for detection of nasal and cutaneous groin colonization by MRSA. J Clin Microbiol (2009) 1.09

Antimicrobial resistance testing of Helicobacter pylori: a comparison of Etest and disk diffusion methods. Pathology (1997) 1.09

Thyroid-associated ophthalmopathy: a practical guide to classification, natural history and management. Intern Med J (2004) 1.09

Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization. Clin Microbiol Infect (2013) 1.09

Vancomycin vintage: my favourite DRESS. Intern Med J (2015) 1.08

Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci. Antimicrob Agents Chemother (1992) 1.07

It's time to move beyond trying to predict mortality using severity assessment tools in community-acquired pneumonia. Intern Med J (2014) 1.07

APOE epsilon4 genotype is associated with an earlier onset of chronic temporal lobe epilepsy. Neurology (2000) 1.07

Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies. Br J Pharmacol (2014) 1.01

The impact of contemporary bladder management techniques on struvite calculi associated with spinal cord injury. BJU Int (1999) 1.00

Protease-activated receptor (PAR) 1 but not PAR2 or PAR4 mediates endothelium-dependent relaxation to thrombin and trypsin in human pulmonary arteries. J Cardiovasc Pharmacol (2001) 1.00

Current indications for open stone surgery in an endourology center. Urology (1995) 0.99

Improved detection of vanB2-containing enterococcus faecium with vancomycin susceptibility by Etest using oxgall supplementation. J Clin Microbiol (2008) 0.99

Comparison of Vero cell assay and PCR as indicators of the presence of verocytotoxigenic Escherichia coli in bovine and human fecal samples. Appl Environ Microbiol (1996) 0.98

Improved renal function following aggressive treatment of urolithiasis and concurrent mild to moderate renal insufficiency. J Urol (1994) 0.97

Fecal colonization with vancomycin-resistant enterococci in Australia. Emerg Infect Dis (2000) 0.97

Assessing the risk of tuberculosis infection among healthcare workers: the Melbourne Mantoux Study. Melbourne Mantoux Study Group. Med J Aust (2001) 0.96

Nd:YAG laser ablation of the prostate as a treatment for benign prostatic hypertrophy. Lasers Surg Med (1992) 0.96

Smoking and varicella pneumonia. J Infect (1988) 0.95

Home-based treatment of cellulitis with twice-daily cefazolin. Med J Aust (1998) 0.93

Severe dapsone syndrome due to weekly maloprim. Lancet (1988) 0.93

Clostridium lavalense sp. nov., a glycopeptide-resistant species isolated from human faeces. Int J Syst Evol Microbiol (2009) 0.93

The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis. J Antimicrob Chemother (1999) 0.93

Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines. Prostate (2008) 0.92

Risk factors for adverse cutaneous reactions associated with intravenous vancomycin. J Antimicrob Chemother (1997) 0.91

A paired comparison of tuberculin skin test results in health care workers using 5 TU and 10 TU tuberculin. Thorax (2000) 0.90

Integrating biosystematic data into conservation planning: perspectives from southern Africa's Succulent Karoo. Syst Biol (2002) 0.90

Prostate cancer: are new prognostic markers on the horizon? Prostate Cancer Prostatic Dis (2000) 0.89

Hospital-in-the-home care: is it worth the hassle? Med J Aust (1998) 0.89

Effects of alendronate on bone density in men with primary and secondary osteoporosis. Osteoporos Int (2000) 0.89

Identification, distribution, and expression of angiotensin II receptors in the normal human prostate and benign prostatic hyperplasia. Endocrinology (2001) 0.88

Polymicrobial septicaemia with Pseudomonas aeruginosa and Streptococcus pyogenes following traditional tattooing. J Infect (1997) 0.88

Hypothermia associated with percutaneous nephrolithotomy. Urology (1994) 0.88

A Case of Osteitis Deformans. J Med Res (1911) 0.87

Electronic estimations of renal function are inaccurate in solid-organ transplant recipients and can result in significant underdosing of prophylactic valganciclovir. Antimicrob Agents Chemother (2013) 0.86

Localization of angiotensin-converting enzyme in the human prostate: pathological expression in benign prostatic hyperplasia. J Pathol (2001) 0.85

Role of the renin-angiotensin system in prostate cancer. Mol Cell Endocrinol (2008) 0.85

The effect of newer generation lithotripsy upon renal function assessed by nuclear scintigraphy. J Urol (1995) 0.84

Endocervicosis of the bladder. J Urol (1995) 0.84

Image guidance for focal therapy of prostate cancer. World J Urol (2010) 0.83

Isoniazid toxicity in health care workers. Clin Infect Dis (1999) 0.83

Neurological complications of chlamydial infections: case report and review. Clin Infect Dis (1997) 0.83

Gabapentin for neuropathic pain following spinal cord injury. Spinal Cord (2002) 0.82

Angiotensin II enhances noradrenaline release from sympathetic nerves of the rat prostate via a novel angiotensin receptor: implications for the pathophysiology of benign prostatic hyperplasia. J Endocrinol (2001) 0.82

Metabolism and elimination of 5,6-dimethylxanthenone-4-acetic acid in the isolated perfused rat liver. Drug Metab Dispos (1995) 0.81

Inducible resistance to clindamycin in Staphylococcus aureus: validation of Vitek-2 against CLSI D-test. Pathology (2013) 0.81

The prevalence of fecal colonization with VRE among residents of long-term-care facilities in Melbourne, Australia. Infect Control Hosp Epidemiol (2001) 0.81

Expression of the prostate cancer metastasis suppressor gene KAI1 in primary prostate cancers: a biphasic relationship with tumour grade. J Pathol (1999) 0.81

Performance of formulas for estimating glomerular filtration rate in Indigenous Australians with and without Type 2 diabetes: the eGFR Study. Diabet Med (2014) 0.81

Significant reduction in vancomycin-resistant enterococcus colonization and bacteraemia after introduction of a bleach-based cleaning-disinfection programme. J Hosp Infect (2012) 0.81

The expression of soluble, full-length, recombinant human TSH receptor in a prokaryotic system. Protein Expr Purif (2001) 0.81

Diarrheal disease in patients infected with human immunodeficiency virus in Bangkok, Thailand. Am J Trop Med Hyg (1999) 0.80

Voiding dysfunction in human immunodeficiency virus infections. J Urol (1996) 0.80

Should follow-up biopsies for men on active surveillance for prostate cancer be restricted to limited templates? Urology (2013) 0.80

Can alcohol-based hand-rub solutions cause you to lose your driver's license? Comparative cutaneous absorption of various alcohols. Antimicrob Agents Chemother (2006) 0.79

18F-fluorodeoxyglucose positron emission tomography in evaluation of germ cell tumor after chemotherapy. Urology (2004) 0.79

Histopathological changes in human prostatic adenoma following neodymium:YAG laser ablation therapy. J Urol (1994) 0.79

Randomised study of the effect of midnight versus 0600 removal of urinary catheters. Br J Urol (1993) 0.78

Cost-effectiveness of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients. Clin Infect Dis (1997) 0.78

Safety of imipenem in neonates. Pediatr Infect Dis J (1995) 0.78

Acceptability of early discharge, hospital at home schemes. Treatments that can be safely and acceptably managed at home need to be defined. BMJ (1998) 0.78

Effect of anti-tuberculosis treatment on the tuberculin interferon-gamma response in tuberculin skin test (TST) positive health care workers and patients with tuberculosis. Int J Tuberc Lung Dis (2000) 0.78

Measurement of thyroid stimulating immunoglobulins in a new cell line transfected with a functional human TSH receptor (JPO9 cells), compared with an assay using FRTL-5 cells. Clin Endocrinol (Oxf) (1994) 0.78

In vivo estimation of changes in distal tubule flow and their role in dexamethasone-induced kaliuresis in control and potassium-adapted rats. Clin Exp Pharmacol Physiol (1987) 0.77

Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia. Clin Microbiol Infect (2012) 0.77